UPDATED Apr 24, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$783.00 | -2.6% | 59.3% | NT$20.3t | NT$912.98 | PE23.7x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£113.52 | 4.5% | -4.2% | UK£176.0b | UK£129.63 | PE36.8x | E16.3% | 2.0% | Pharmaceuticals & Biotech | ||
NOVN | CHF89.12 | 5.0% | -2.8% | CHF181.8b | CHF98.86 | PE21.8x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF222.20 | 1.0% | -19.1% | CHF179.0b | CHF281.06 | PE15.4x | E8.2% | 4.3% | Pharmaceuticals & Biotech | ||
AIR | €162.22 | 1.5% | 30.7% | €127.7b | €175.62 | PE33.7x | E17.7% | 1.1% | Capital Goods | ||
SLB | US$49.11 | -3.3% | 2.8% | US$70.8b | US$67.11 | PE16.2x | E13.1% | 2.2% | Energy | ||
ZURN | CHF446.30 | 0.1% | 4.7% | CHF64.3b | CHF459.14 | PE16.1x | E8.6% | 5.8% | Insurance | ||
NTES | US$94.02 | 4.5% | 9.5% | US$58.2b | US$132.85 | PE14.5x | E7.9% | 2.7% | Media | ||
BBRI | Rp5,300.00 | 0% | 5.5% | Rp799.2t | Rp6,681.54 | PB2.6x | E11.3% | 6.0% | Banks | ||
2454 | NT$1,010.00 | -3.8% | 55.6% | NT$1.6t | NT$1,199.29 | PE20.9x | E14.0% | 6.0% | Semiconductors | ||
600809 | CN¥249.09 | 2.4% | 3.8% | CN¥303.9b | CN¥290.03 | PE29.2x | E16.6% | 1.3% | Food, Beverage & Tobacco | ||
BMRI | Rp7,050.00 | 6.4% | 35.6% | Rp637.0t | Rp7,544.68 | PB2.5x | E9.4% | 5.0% | Banks | ||
2020 | HK$89.35 | 9.5% | -7.1% | HK$253.1b | HK$111.82 | PE22.9x | E13.0% | 2.6% | Consumer Durables | ||
300124 | CN¥59.18 | -4.2% | -3.1% | CN¥158.3b | CN¥74.25 | PE32.9x | E16.3% | 0.6% | Capital Goods | ||
ALL | AU$41.07 | 3.5% | 9.2% | AU$26.0b | AU$47.49 | PE17.9x | E5.1% | 1.7% | Consumer Services | ||
SOON | CHF255.20 | 2.3% | -8.5% | CHF15.2b | CHF270.88 | PE25.3x | E10.7% | 1.8% | Healthcare | ||
KCHOL | ₺212.00 | -2.3% | 173.5% | ₺537.6b | ₺215.07 | PE7.4x | E26.5% | 3.8% | Capital Goods | ||
2027 | CN¥7.00 | -0.8% | 12.5% | CN¥101.1b | CN¥8.02 | PE23.7x | E19.0% | 6.0% | Media | ||
JMT | €18.63 | 5.1% | -14.5% | €11.7b | €23.39 | PE15.5x | E6.7% | 3.5% | Consumer Retailing | ||
HTHT | US$39.16 | 3.8% | -15.2% | US$12.3b | US$52.40 | PE22.1x | E10.7% | 3.1% | Consumer Services | ||
300122 | CN¥34.08 | -19.1% | -36.7% | CN¥81.6b | CN¥64.77 | PE10.9x | E25.9% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥40.09 | 4.8% | -10.3% | CN¥81.1b | CN¥49.40 | PE36.4x | E21.2% | 2.5% | Software | ||
2050 | CN¥21.94 | 5.0% | -6.5% | CN¥78.6b | CN¥31.83 | PE25.3x | E19.2% | 1.1% | Capital Goods | ||
DOX | US$86.74 | 2.1% | -2.9% | US$10.1b | US$104.90 | PE18.1x | E15.8% | 2.2% | Software |